006, OR = 1 69) Additionally, SNP rs7623768 and the haplotype G–

006, OR = 1.69). Additionally, SNP rs7623768 and the haplotype G–C of rs4076086–rs7623768 in CRTAP is associated with femoral neck BMD (p = 0.009 and p = 0.003, respectively). PTHR1

showed haplotypic associations with lumbar spine and femoral neck BMD (p = 0.02 and p = 0.044, respectively). Mutations in FLNB have been observed in a number of human skeletal disorders, including boomerang dysplasia [16], Larson #Akt inhibitor randurls[1|1|,|CHEM1|]# syndrome [17, 18], spondylocarpotarsal synostosis [18, 19], and atelosteogenesis I and III [18, 20]. Together with the intense and uniform FLNB expression detected throughout the growth plate in normal mouse embryos in resting, proliferating, and prehypertrophic and hypertrophic chondrocytes, it is thought that FLNB plays a central role in skeletogenesis and joint formation [18]. Interestingly, a number of mutations that lead to the broad phenotypic spectrum are located within the actin-binding domain of FLNB. A functional actin cytoskeleton may be important for many normal morphogenetic processes, including skeletogenesis [16]. The phenotypes of FLNB-deficient

mice also revealed the importance of the gene in skeletogenesis. FLNB −/− mice have vertebral fusions and abnormalities and decreased hyaline cartilage in the vertebral, carpal, and tarsal bones I-BET-762 cell line (Table 1) similar to the human clinical malformations seen in vertebral segmentation, joint formation, and skeletogenesis in the syndromes of spondylocarpotarsal syndrome [22, 23], atelosteogenesis I and III [23], Larsen syndrome [23], and boomerang dysplasia [23]. Scoliotic and kyphotic abnormalities of the vertebral column in FLNB −/− mice resemble those observed in human boomerang dysplasia [23]. In addition to these monogenic bone diseases, FLNB is also associated with human BMD measured at various sites. SNPs rs9822918 and rs2177153 Niclosamide were associated with age-corrected BMD at both the femoral neck (p = 0.02–0.0002) and total hip (p = 0.02–0.0006) in 771 women from the GENOS sib-pairs study [21]. Such association was replicated in a

population-based cohort of 1,192 unrelated Caucasian women from the CAIFOS (CAlcium Intake Fracture Outcome Study)/CARES (Caring for Adults Recovering from the Effects of Stroke) study [21]. Both rs9822918 and rs2177153 were included in our present study. In our cohort, rs9822918 was also significantly associated with total hip BMD (p = 0.017, OR = 1.55). No association was nevertheless observed for rs2177153 (p > 0.05). The large discrepancy between the MAF of rs2177153 in Caucasian (MAF = 0.292 from HapMap) and southern Chinese women (MAF = 0.02 from the present study) may explain the association difference. Kiel et al. [47] used the Affymetrix 100K SNP GeneChip marker set in the Framingham Heart Study to examine genetic associations with BMD. Two SNPs in FLNB were included in the 100K marker set. According to the results available at http://​www.​ncbi.​nlm.​nih.​gov/​projects/​gap/​cgi-bin/​study.​cgi?​study_​id=​phs000007.

Comments are closed.